NCT07518043 2026-04-15
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
Clinical Trials
13 trialsNCT07519655 2026-04-09
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Pfizer
Phase 1 Not yet recruiting
NCT07476326 2026-04-03
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Biocon Limited
Phase 1 Not yet recruiting
NCT07475572 2026-03-16
A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
Alvotech Swiss AG
Phase 1 Not yet recruiting
NCT07237594 2026-03-11
REPLAY
Duke University
Phase 1 Not yet recruiting
NCT07444606 2026-03-03
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT07320222 2026-01-06
CARE-Melanoma
McMaster University
Phase 1 Not yet recruiting
NCT07252661 2025-11-28
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
AccSalus Biosciences, Inc.
Phase 1 Not yet recruiting
NCT06897735 2025-11-18
EDDIS-a1
Petrov, Andrey
Phase 1 Not yet recruiting
NCT07177937 2025-09-22
A Study of DXC014 in Patients With Advanced Solid Tumors.
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1 Not yet recruiting
NCT07183852 2025-09-19
GoTIL-01
Vastra Gotaland Region
Phase 1 Not yet recruiting
NCT06424626 2024-05-22
A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
Peking University Cancer Hospital & Institute
Phase 1 Not yet recruiting
NCT05903937 2023-06-15
HAITILS-PHP
Vastra Gotaland Region
Phase 1 Not yet recruiting